Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Chindex Forges JV with Fosun Pharma

publication date: Jun 14, 2010
Chindex International has entered a medical device distribution JV with Shanghai Fosun Pharmaceutical Group. If all conditions are met, Fosun will purchase $30 million of equity in Chindex, about 10% of the total, which will bring its ownership of Chindex up to 25%. Some details of the arrangement remain to be worked out. More details...

Stock Symbols: (NSDQ: CHDX) (SHA: 600196)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China